About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the future of humanity.
Jan 31, 2018...
SPENCER HEYFRON FOR READER'S DIGEST
In 2008, just after she’d started kindergarten, Tori Lee was diagnosed with acute lymphoblastic leukemia (ALL), an aggressive form of blood cancer. Chemotherapy cures most children of the disease, but Tori wasn’t as lucky. A playful little girl who was doted on by her three older sisters, she “was treated with chemotherapy for about two years, and then she relapsed,” says her mother, Dana Lee. “We started a new protocol, with more intensive chemotherapy and radiation. She spent hundreds of days in the hospital.” And still the cancer held on.
Jul 26, 2018...
The Bladder EpiCheck diagnostic kit developed by Nucleix Ltd. (Courtesy)
Israeli startup Nucleix Ltd., a cancer detection screening company, has developed a urine test that it says can detect with high levels of accuracy the recurrence of bladder cancer in patients.
The company’s diagnostic kit studies a patient’s urine for changes in the DNA of the cells that could signal the repeated onset of cancer. “Ours is a noninvasive, very sensitive and cost effective liquid biopsy test,” said Dr. Opher Shapira, the CEO of Nucleix, in a phone interview.
https://www.weizmann-usa.org/news-media/news-releases/science-tips-february-2013/
Feb 07, 2013... Before they go all-out supernova, certain large stars undergo a sort of “mini-explosion,” throwing a good-sized chunk of their material off into space. Though several models predict this behavior and evidence from supernovae points in this direction, actual observations of such pre-explosion outbursts have been rare. In new research led by Dr. Eran Ofek of the Weizmann Institute of Science, scientists found such an outburst taking place a short time — just one month — before a massive star underwent a supernova explosion.
Jan 28, 2015...
Prof. Moshe Oren, Head, Moross Integrated Cancer Center
Several decades after President Nixon declared war on cancer, it remains one of the most common and deadliest diseases worldwide, with scientists still working feverishly to unravel the complexities that make fighting it – much less defeating it – so difficult. The Weizmann Institute of Science realized that a different way of looking at cancer was needed – a holistic approach that considers cancer in its totality, that incorporates information from the genomics revolution, that harnesses the power of personalized medicine.
Sep 25, 2017...
Being diagnosed with breast cancer can make a person feel powerless, but there are some things women can do to potentially improve how they feel throughout the process. Here are some strategies recommended by experts—and others that are still being explored—which may help improve the effectiveness and symptoms of treatment.
Physical activity
“Exercise is one of the best things women can do for themselves,” says Dr. Ann Partridge, director of the Program for Young Women with Breast Cancer at Dana-Farber Cancer Institute . “It doesn’t mean marathons or hot yoga, but walking three to five times a week can make a huge difference it terms of energy, stamina and how you feel during treatment.” Partridge says that while exercising during treatment won't be easy for every woman with breast cancer, it can be worthwhile if there days during treatment cycles where women feel up to it.
Jul 23, 2015...
Photo via www.shutterstock.com
Lung cancer patients know that the statistics for a full recovery are not in their favor, but new research coming out of Israel could alter these grim figures. According to the Weizmann Institute of Science’s Prof. Yosef Yarden, an innovative strategy involving a three-pronged approach might keep an aggressive form of lung cancer at bay.
Yarden and his lab staff showed on mouse models that their approach stops lung cancer cells from developing resistance to chemotherapy.
May 20, 2013...
Emily Whitehead, 8, celebrates a year of remission after cancer therapy at Children's. Photo from The Philadelphia Inquirer
It is vanishingly rare for an experimental treatment to wipe out advanced, recurrent cancer, then keep the disease from coming back.
Yet therapies driven by CARs have been doing exactly that in a small but growing number of blood-cancer patients at the University of Pennsylvania and other centers.
https://www.weizmann-usa.org/news-media/feature-stories/cancer-research-understanding-the-p53-gene/
Dec 01, 2006...
In their quest to better understand, prevent, and treat cancer, Weizmann Institute of Science researchers are getting to the heart of the matter by exploring the genetics of the disease.
Prof. Varda Rotter, head of the Institute's Department of Molecular Cell Biology, studies p53, a gene that suppresses tumor growth and may one day open doors to the development of new cancer treatment drugs. "There is really a strong feeling that a critical breakthrough in preventing cancer and designing future therapies will occur once it is understood how this gene works," said Prof. Rotter.
https://www.weizmann-usa.org/news-media/feature-stories/june-is-men-s-health-month/
Jun 01, 2012...
Anchored by a Congressional health education program, Men’s Health Month aims to heighten awareness of preventable health problems and encourage early detection and treatment of disease.
The broad-ranging research of Weizmann Institute scientists addresses multiple areas of men’s health, including fighting cancers that are common to men. According to the Centers for Disease Control (CDC), “Every year, cancer claims the lives of nearly 300,000 men in America.” Weizmann research, such as a method for timely detection of prostate cancer, can help protect our fathers, brothers, husbands, friends. Read on for just a few examples of how Institute science is benefitting men’s health.
Aug 15, 2016...
Basel, August 15, 2016 - Today Novartis announced that six scientists will receive the 2016 Novartis Prizes for Immunology at the upcoming 16th International Congress of Immunology (ICI) in Melbourne, Australia on Aug 22, 2016.
The Novartis Prizes for Immunology are awarded every three years for breakthrough contributions to the fields of basic and clinical immunology. Each of the two Prize categories is endowed for CHF 100,000 and can be shared by up to three scientists.
©2023 American Committee for the Weizmann Institute of Science
